Transcode Therapeutics Announces FDA Clearance to Initiate Phase 1/2 Clinical Trial With Ttx-Mc138 in Patients With Advanced Solid Tumors
Transcode Therapeutics宣佈批准啓動針對晚期實體瘤患者的Ttx-Mc138的1/2期臨床試驗
Transcode Therapeutics Announces FDA Clearance to Initiate Phase 1/2 Clinical Trial With Ttx-Mc138 in Patients With Advanced Solid Tumors
Transcode Therapeutics宣佈批准啓動針對晚期實體瘤患者的Ttx-Mc138的1/2期臨床試驗
使用瀏覽器的分享功能,分享給你的好友吧